Convatec (LSE:CTEC)
ConvaTec is a global medical products and technologies company, specialising in ostomy care, wound therapeutics, continence and critical care, and infusion devices.
About
Last updated 09-04-2021, 04:30:00pm BSTRelated Articles
-
3 FTSE 250 stocks I think could soar into the FTSE 100 index in 2021
From a national institution to a worldwide veterinarian favourite, here are 3 FTSE 250 stocks this Fool thinks could gatecrash the FTSE 100 index... Read More »
-
3 FTSE 250 recovery stocks I’d buy now to get rich and retire early
I think these three FTSE 250 recovery stocks are strong candidates to deliver high returns. They're among my best shares to buy now. Read More »
-
Stock market crash: 3 cheap shares I’d buy to make a million
The stock market crash sent these shares plunging to low levels. Buying them while they're cheap could produce high total returns in the years... Read More »
-
Calling ISA investors! A FTSE 250 turnaround stock I’d buy for 2020 and beyond
I'd buy this brilliant defensive hero for 2020 and hold it for years to come, says Royston Wild. Read More »
-
2 FTSE 250 stocks I’d buy for 2020
G A Chester highlights two FTSE 250 (INDEXFTSE:MCX) stocks where he sees catalysts for high investment returns. Read More »
-
Should I buy this turnaround stock, up 15% today?
Why I’m optimistic about this stock’s forward prospects and what I’d do next. Read More »
-
2 FTSE 250 turnaround stocks I’d buy right now
G A Chester sees strong turnaround potential in these two FTSE 250 (INDEXFTSE:MCX) stocks. Read More »
-
3 top FTSE 250 value stocks I’d buy today
These unloved FTSE 250 (INDEXFTSE: MCX) dividend stocks look too cheap to Roland Head. Read More »
-
I got this FTSE 250 stock badly wrong. But could the time to buy now be right?
G A Chester revisits a disastrous FTSE 250 (INDEXFTSE:MCX) stock tip, and considers its current valuation and prospects. Read More »
-
Is this dividend-paying mid-cap a steal, down 20% today?
Why I think the market reaction to this quality firm’s update looks fair, but the share now has decent recovery potential. Read More »